US Executive Compensation Proxy SEC Filings — May 05, 2026

05-05-2026

Orgenesis Inc. (ORGS) has filed a DEF 14A proxy statement for a virtual Special Meeting of stockholders on May 27, 2026, soliciting votes on three proposals: (1) amending the Articles of Incorporation to increase authorized common shares from 14,583,333 to 150,000,000; (2) approving a Convertible Loan Agreement dated September 10, 2025, with Theracell Laboratories IKE and Alpha Prosperity Fund SPC that may result in share issuance; and (3) ratifying Kesselman & Kesselman C.P.A.s as independent auditors for FY 2025. Record date is April 22, 2026, with 9,799,538 common shares outstanding entitled to vote. The Board recommends voting 'FOR' all proposals; no financial performance metrics are discussed.

• ·Special Meeting at 10:00 a.m. EST on May 27, 2026, via live audio webcast; registration required by 11:59 p.m. ET on May 26, 2026 at https://onlineproxyvote.com/ORGS/2026.
• ·Proposal 1 (Charter Amendment) requires majority of votes cast; brokers have discretionary authority.
• ·Proposal 2 (Share Issuance) requires majority of votes cast; no broker discretionary authority (broker non-votes possible).
• ·Proposal 3 (Auditor Ratification) requires majority of shares present or represented by proxy; brokers have discretionary authority.
• ·Proxy materials distributed on or about April 30, 2026.

05-05-2026

Range Capital Acquisition Corp., a blank check company post-IPO on December 23, 2024, is seeking shareholder approval via proxy statement to extend its business combination deadline from June 23, 2026 to December 23, 2026 (24 months from IPO), to allow more time to identify and complete a deal. The Trust Account holds approximately $121,936,241.23 as of May 1, 2026, up from $115,575,000 post-IPO, but approval risks significant redemptions that could deplete funds substantially, potentially leaving insufficient capital for a business combination without additional financing. Sponsor and insiders, holding 3,708,333 Founder Shares (23.1%), intend to vote in favor.

• ·Extraordinary General Meeting to vote on proposals; Extension requires 2/3 majority special resolution, Adjournment requires majority ordinary resolution.
• ·If extension not approved, liquidation by June 23, 2026 with Public Shares redeemed at pro rata Trust value (less taxes and up to $100,000 expenses).
• ·Sponsor, directors, officers, and advisors intend to vote all Founder Shares in favor; may purchase additional Public Shares to support approval.
• ·No redemption rights for rights, which expire worthless in liquidation; Founder Shares receive no Trust distributions.

05-05-2026

Hyperion DeFi, Inc. (HYPD) has issued a proxy statement for its virtual-only 2026 Annual Meeting of Stockholders on June 30, 2026 at 12:00 PM ET, with a record date of May 4, 2026, when 12,219,295 shares of common stock were outstanding. Stockholders will vote on five proposals: electing five directors for one-year terms, ratifying CBIZ CPAs P.C. as independent auditors for FY2026, advisory approval of named executive officer compensation, amending and restating the charter to permit stockholder action by written consent, and approving adjournment if needed for Proposal 4. A quorum of 33% of outstanding shares is required, with proxy materials available online starting May 11, 2026.

• ·Meeting hosted virtually at https://web.viewproxy.com/hypd/2026; registration required by June 29, 2026 at 11:59 PM ET.
• ·Proposal 1 (director election): plurality vote; Proposals 2 and 5 (auditor ratification and adjournment): majority of shares present; Proposals 3 and 4 (say-on-pay and charter amendment): majority of shares present or outstanding shares respectively.
• ·Annual Report on Form 10-K for FY ended December 31, 2025 available at www.sec.gov, company IR site, or by request.
• ·Principal executive offices: 3090 Nowitzki Way, Suite 300, Dallas, TX 75219.

05-05-2026

FibroBiologics, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 22, 2026, virtually at www.virtualshareholdermeeting.com/FBLG2026, seeking approval for electing one Class III director, ratifying WithumSmith+Brown, PC as independent auditor for the year ending December 31, 2026, approving issuance of up to 2,272,728 shares from March 2026 SPA warrants and 159,091 shares from the H.C. Wainwright Engagement Letter, and approving the 2026 Equity and Incentive Compensation Plan. The record date is April 24, 2026, with 5,208,915 common shares outstanding and 125 Series C Preferred shares (held by CEO Pete O’Heeron) providing 1,625,000 votes (~24% of total) via irrevocable proxy to the Board. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Annual Meeting record date: April 24, 2026.
• ·Meeting time: 11:00 a.m. Central Time, virtual only.
• ·Board recommends FOR all proposals; Series C proxy votes FOR proposals.
• ·Proxy materials mailed on or about May 5, 2026.

05-05-2026

FONAR CORP's DEF 14A proxy statement discloses beneficial ownership as of April 20, 2026, with 6,173,008 shares of Common Stock, 146 shares of Class B Common Stock, and 382,513 shares of Class C Common Stock outstanding; Timothy Damadian beneficially owns 1.29% of Common Stock and 99.98% of Class C, indicating significant control. Executive compensation for FY2025 shows Timothy R. Damadian receiving $295,000 (down 21% from $372,885 in FY2024), while Luciano Bonanni's total remained flat at $498,241; directors received $20,000 cash fees plus additional compensation. The filing seeks approval for director elections, advisory vote on executive compensation, and ratification of CohnReznick LLP as auditors for FY2026.

• ·No separate standing nominating or compensation committees; Board handles as a whole.
• ·No stock options or SARs granted or exercised in FY2025.
• ·Audit committee members: Ronald G. Lehman, Richard E. Turk, Jessica Maher (all independent).
• ·Company maintains no pension or deferred compensation plans except 401(k).

05-05-2026

05-05-2026

05-05-2026

ServiceTitan, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on June 17, 2026 (virtual) proposes the election of three Class II directors (Michael Brown, Byron Deeter, Vahe Kuzoyan), ratification of PricewaterhouseCoopers LLP as independent auditors for FY ending January 31, 2027, and an advisory vote recommending annual frequency for future say-on-pay votes. The record date is April 22, 2026, with 82,736,786 Class A shares (1 vote each) and 12,651,154 Class B shares (10 votes each) outstanding. Board recommendations are FOR all proposals, with no reported controversies or declines noted.

• ·Annual Meeting date and time: Wednesday, June 17, 2026 at 12:00 PM PT (virtual at www.virtualshareholdermeeting.com/TTAN2026)
• ·Proxy materials first distributed on or about May 5, 2026
• ·Fiscal year ends January 31; auditors appointed for year ending January 31, 2027
• ·Board of Directors: 9 members, 8 independent (all except CEO Ara Mahdessian)

05-05-2026

Beyond Air, Inc. is holding a special meeting to seek stockholder approval for a fourth amendment to its certificate of incorporation, authorizing a reverse stock split of common stock at a board-determined ratio between 1-for-2 and 1-for-20, within one year, primarily to address Nasdaq delisting risk due to failing the $1.00 minimum bid price rule for 30 consecutive business days from February 23 to April 6, 2026. This follows a prior 1-for-20 reverse split on July 14, 2025, and a recent Nasdaq notice on April 7, 2026, with a hearing scheduled for May 14, 2026; delisting could lead to OTC trading, reduced liquidity, capital raising challenges, and potential total loss for stockholders in restructuring. The board unanimously recommends approval, with 12,692,684 shares outstanding as of the April 20, 2026 record date.

• ·Nasdaq delisting notice received April 7, 2026, after 30 consecutive business days of sub-$1.00 bid price from February 23 to April 6, 2026.
• ·Prior 1-for-20 reverse stock split effected July 14, 2025.
• ·Nasdaq hearing requested April 13, 2026, scheduled for May 14, 2026.
• ·Proxy voting deadline: 11:59 P.M. Eastern time on June 17, 2026.
• ·Special Meeting location: 900 Stewart Avenue, Suite 301, Garden City, New York 11530.

05-05-2026

Workday, Inc.'s DEF 14A Proxy Statement for the 2026 Annual Meeting on June 16, 2026, recommends voting FOR the election of four Class II directors (Wayne A.I. Frederick, M.D., Mark J. Hawkins, Rhonda J. Morris, and George J. Still, Jr.), ratification of Ernst & Young LLP as auditors, advisory approval of named executive officer compensation, and amendments to increase shares under the 2022 Equity Incentive Plan and 2012 Employee Stock Purchase Plan. The Board recommends AGAINST two stockholder proposals seeking disclosure of employee retention rates by demographic category and voting results by share class. Governance highlights include a Board of 11 members (10 independent, average tenure ~7.75 years, 55% women or minorities) with strong oversight on strategy, risks, and human capital.

• ·Record Date: April 17, 2026
• ·Voting deadline: 11:59 p.m. EDT on June 15, 2026
• ·Class A common stock: 1 vote per share; Class B common stock: 10 votes per share
• ·Board added three new directors in the last two fiscal years
• ·Fiscal year ends January 31

05-05-2026

Sonoma Pharmaceuticals, Inc. filed a DEF 14A proxy statement dated May 5, 2026, for a Special Meeting of Shareholders on June 24, 2026, at 2:00 p.m. MDT in Boulder, CO, to vote on Proposal 1: authorizing reincorporation from Delaware to Nevada, and Proposal 2: potential adjournment for additional proxies if needed. The Plan of Conversion specifies a 1:1 share conversion, continuity of directors and officers, and new Nevada governing documents, with no other business anticipated.

• ·Fiscal year end: March 31
• ·2025 Annual Report on Form 10-K filed with SEC on June 17, 2025
• ·Stockholder proposals for 2027 proxy due no later than 120 days before 2026 proxy publication anniversary

05-05-2026

CrowdStrike Holdings, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 17, 2026, to elect Class I directors Johanna Flower and Denis J. O’Leary, ratify PricewaterhouseCoopers LLP as auditors for FY2027, approve an amendment limiting officer liability, and advisory ratify supermajority voting provisions. Fiscal 2026 results showed strong growth with total revenue of $4.81 billion (+22% YoY), ending ARR of $5.25 billion (+24% YoY), net cash from operations of $1.61 billion (34% of revenue), and free cash flow of $1.24 billion (26% margin), alongside 97% gross retention and robust module adoption (50% of customers with 6+ modules). No declines or flat metrics were reported.

• ·Annual Meeting record date: April 24, 2026
• ·Fiscal year end: January 31
• ·Cloud security, next-gen identity protection, and LogScale next-gen SIEM ending ARR surpassing $1.9 billion as of January 31, 2026
• ·Board recommends 'FOR' all four proposals